COSCIENS BIOPHARMA INC (CSCI) Stock Cash Flow
NASDAQ:CSCI - Nasdaq - CA22112H1010 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.21M | -15.31M | -16.55M | -22.73M | -8.37M | |||
| Depreciation Amortization | 1.89M | 1.61M | 1.44M | 140.00K | 150.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.73M | -1.77M | 153.00K | 1.44M | 900.00K | |||
| Taxes Paid | N/A | N/A | -1.33M | -830.00K | 1.61M | |||
| Other non cash items | 891.00K | 905.00K | -693.00K | 7.48M | -1.25M | |||
| OPERATING CASH FLOW | -12.16M | -14.57M | -2.58M | -13.68M | -8.58M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.77M | -1.16M | -722.00K | -10.00K | -640.00K | |||
| Other Investing Activity | N/A | 26.24M | -8.00K | 0.00 | -20.00K | |||
| INVESTING CASH FLOW | 24.47M | 25.08M | -730.00K | -10.00K | -660.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -579.00K | -421.00K | -370.00K | -130.00K | -130.00K | |||
| Stock Issued/Repurchased | N/A | -167.00K | 13.00K | 0.00 | 54.29M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 20.00K | -3.12M | |||
| FINANCING CASH FLOW | -746.00K | -588.00K | -357.00K | -120.00K | 51.04M | |||
| Exchange Rate Effect | -18.00K | -212.00K | 157.00K | -880.00K | -770.00K | |||
| CHANGE IN CASH | 11.55M | 9.71M | -3.51M | -14.69M | 41.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.16M | -14.57M | -2.58M | -13.68M | -8.58M | |||
| Capital Expenditure | -1.77M | -1.16M | -722.00K | -10.00K | -640.00K | |||
| FREE CASH FLOW | -13.93M | -15.73M | -3.30M | -13.69M | -9.22M | |||
All data in USD